Vimarsana
Biggest News Aggregation in the World

Peer Schatz News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Peer Schatz. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Peer Schatz Today - Breaking & Trending Today

CENTOGENE Explores Strategic Alternatives - Vimarsana News

CENTOGENE Explores Strategic Alternatives

CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, Feb. 28, 2024 -- Centogene N.V. , the essential life science partner for data-driven answers in rare and neurodegenerative diseases, today...

CENTOGENE Reports First Half 2023 Financial Results - Vimarsana News

CENTOGENE Reports First Half 2023 Financial Results

Strong Revenues and Steady Growth in Both Diagnostics and Pharma Segments Drive Sustainable Financial PerformanceFirst half 2023 total revenues with double-digit growth of 15.1% at €24.6 millionBoth...

CENTOGENE Reports First Half 2023 Financial Results - Centogene (NASDAQ:CNTG) - Vimarsana News

CENTOGENE Reports First Half 2023 Financial Results - Centogene (NASDAQ:CNTG)

First half 2023 total revenues with double-digit growth of 15.1% at €24.6 millionBoth Pharma and Diagnostics segments deliver strong performance, reaffirming full year 2023 guidance for total revenue growth between 10%

CENTOGENE Announces Approval of All Resolutions Tabled at 2023 Annual General Meeting - Vimarsana News

CENTOGENE Announces Approval of All Resolutions Tabled at 2023 Annual General Meeting

CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, June 30, 2023 -- CENTOGENE N.V. , the essential life science partner for data-driven answers in rare and neurodegenerative diseases, today...

CENTOGENE Announces Shareholder Approval of All Resolutions at 2022 Annual General Meeting - Vimarsana News

CENTOGENE Announces Shareholder Approval of All Resolutions at 2022 Annual General Meeting

27.06.2022 - CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, June 27, 2022 (GLOBE NEWSWIRE) - Centogene N.V. (Nasdaq: CNTG), the commercial-stage, essential biodata life science partner for rare and neurodegenerative diseases, today announced the voting ... Seite 1